Asensus Surgical Inc (ASXC)
$0.26
0.0047 (1.83%)
ASXC Stock Quote Delayed 30 Minutes
ASXC Stock Earnings: Asensus Surgical Misses EPS, Misses Revenue for Q1 2024
ASXC stock results show that Asensus Surgical missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
71.21M
PE Ratio
-3.74
EPS
-0.07
Volume (Avg. Vol.)
787,835
Day's Range
$0.25 - $0.27
52-Week Range
$0.20 - $0.65
Dividend & Yield
N/A (N/A)
ASXC Stock Predictions, Articles, and Asensus Surgical Inc News
Why Is Asensus Surgical (ASXC) Stock Up 18% Today?
Asensus Surgical (ASXC) stock is rising higher on Thursday as investors react to news of a collaboration with Nvidia NVDA).
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Good morning, investor! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!
Asensus Is a Bet on the Push to Reduce Robotic Surgery Costs
ASXC stock's growth potential is tied to preferences for costly robotic surgery and the ability of the Senhance System to reduce those costs.
If You’re Buying The Asensus Surgical Stock Rebound, Watch Out
For those looking for short-term trades, this could still end up being a profitable opportunity. But, considering its history of disappointments, don't be surprised if sentiment for ASXC stock once again turns on a dime.
Asensus Surgical Stock Is Coiling for the Next Move Higher
As Asensus pioneers a new standard of digitally enhanced surgery, ASXC stock holders should stay patient and hold on for the long term.
Asensus Surgical Investors Need To Take Long-Term View on Its Technology
Asensus claims its Senhance can do a hysterectomy for half what Intuitive's DaVinci robot costs, with renewable instruments and haptic feedback. The long haul is the only way to play ASXC stock.
ASXC Stock: Why Popular Play Asensus Surgical Is Climbing Today
ASXC stock got an analyst 'buy' rating just days after reporting positive Q1 results. Asensus Surgical remains a worthy investment.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investors! Join us as we kick off the day with a look at the biggest pre-market stock movers for Wednesday.
Hold Asensus Surgical Stock as Next-Gen Senhance System Gains Traction
ASXC stock holders should appreciate the company's ambitious vision as Asensus introduces its innovative surgical tech into multiple regions.
Asensus Surgical Is a Great Investment, but Not Much of a Retail Trade
ASXC stock is an interesting play in the digital surgery space, especially with surgery numbers expected to pick up in the coming months.
ASXC Stock: Why Penny Stocks Play Asensus Surgical Is Soaring Today
Today, investors in ASXC stock are seeing some very nice gains as optimism grows in the surgical sector coming out of this pandemic.
Asensus Surgical Can’t Support This Valuation and Won’t Anytime Soon
ASXC stock rode the Reddit rally up. Now the business has to deliver — but there's simply not enough evidence to bet on that happening.
Investing in Asensus Surgical Requires the Patience of a Surgeon
ASXC stock is extremely overvalued. And that means that investors may be waiting a long time for the stock to meet its lofty expectations.
Investors Should Pass On Unreliable Asensus Surgical
ASXC stock has been pushed higher by retail investors on Reddit. If it weren't for those investors, the stock would be trading under $1.
Despite Name Change, Asensus Stock Is Still One to Avoid
With the jury still out whether its Sehance digital-surgery system is finally ready for primetime, there's no use buying into ASXC stock at today's inflated price.
